Longley, Jemma http://orcid.org/0000-0002-3829-0686
Johnson, Peter W. M.
Article History
Accepted: 31 March 2021
First Online: 3 May 2021
Declarations
:
: Jemma Longley declares that she has no conflict of interest. Peter W.M. Johnson has received research funding from Epizyme and Janssen, and has received compensation for service as a consultant from Epizyme, Janssen, Takeda, Bristol-Myers Squibb, Novartis, Celgene, Boehringer Ingelheim, Kite Pharma, Genmab, Incyte Corporation, MorphoSys, and Kymera Therapeutics.
: This article does not contain any studies with human or animal subjects performed by the authors